Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia.

× No keyword cloud information.

6 in total

Review 1. Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors: Thomas Force; Kyle L Kolaja
Journal: Nat Rev Drug Discov Date: 2011-02 Impact factor: 84.694

Review 2. Cardiovascular Complications of Targeted Therapies for Chronic Myeloid Leukemia.

Authors: Rongras Damrongwatanasuk; Michael G Fradley
Journal: Curr Treat Options Cardiovasc Med Date: 2017-04

3. Antidiabetic Effects of the Senolytic Agent Dasatinib.

Authors: Omid Salaami; Chia-Ling Kuo; Matthew T Drake; George A Kuchel; James L Kirkland; Robert J Pignolo
Journal: Mayo Clin Proc Date: 2021-11-09 Impact factor: 7.616

4. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.

Authors: D Mokhtari; A Al-Amin; K Turpaev; T Li; O Idevall-Hagren; J Li; A Wuttke; R G Fred; P Ravassard; R Scharfmann; A Tengholm; N Welsh
Journal: Diabetologia Date: 2013-03-05 Impact factor: 10.122

Review 5. Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.

Authors: Javid J Moslehi; Michael Deininger
Journal: J Clin Oncol Date: 2015-09-14 Impact factor: 44.544

6. Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro.

Authors: Dariush Mokhtari; Tingting Li; Tao Lu; Nils Welsh
Journal: PLoS One Date: 2011-09-14 Impact factor: 3.240

6 in total